Generic Drug Manufacturer - Pharma

Relevant Publications

Estimating a Drug\'s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold.

Issue Release: 2024

Generic Drugs and the Struggle to Compete: The Role of Skinny Labels.

Issue Release: 2024

Trend of sales revenue by year for top selling cancer drugs in the US and the effect of loss of market exclusivity.

Issue Release: 2024

Blockchain Adoption for Generic Drugs in the Medicine Supply Chain with Consumers\' Risk-Aversion: A Game-Theoretic Model Within Chinese Legal Framework.

Issue Release: 2024

On the motivation for pharmaceutical manufacturer coupons: Brand loyalty or customer acquisition?

Issue Release: 2024

Manufacturer-sponsored drug coupon use and drug-switching behavior among patients with type 2 diabetes.

Issue Release: 2024

Study of Polymer Component Migrated in Medicinal Product From Transportation Packaging Component: A Systematic Assessment beyond Regulatory Expectations.

Issue Release: 2024

Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study.

Issue Release: 2023

Identifying drugs with the greatest increases and decreases in spending per beneficiary using Medicare Part D: A cross-sectional study.

Issue Release: 2023

A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 Diabetes.

Issue Release: 2023

Multidimensional isotope analysis of carbon, hydrogen, and oxygen as a tool for traceability of lactose in drug products.

Issue Release: 2023

A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States.

Issue Release: 2023

The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian\'s structure-process-outcome framework.

Issue Release: 2023

Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising.

Issue Release: 2023

Market Dynamics of Authorized Generics in Medicaid from 2014 to 2020.

Issue Release: 2023

Inflationary Rebates For Generic Drugs Sold Through Medicaid Saved Billions During 2017-20.

Issue Release: 2023

Shortages of agents used to treat antimuscarinic delirium.

Issue Release: 2023

Comparison of Price Index Methods and Drug Price Inflation Estimates for Hepatitis C Virus Medications.

Issue Release: 2023

The story of the development of generic lenalidomide: How one company thwarted the Waxman-Hatch Act to generate billions of dollars in revenue.

Issue Release: 2023

The Impact of Tirzepatide and Glucagon-like Peptide 1 Receptor Agonists on Oral Hormonal Contraception.

Issue Release: 2023

What are the Key Challenges?

How Do Pharmacists Contribute to Patient Care?

What is the Future of ADE Management?

How Long Does the Approval Process Take?

How Do Collaborative Care Models Work?

What is an Abbreviated New Drug Application (ANDA)?

What Should Be Included in Patient Education Materials?

What is Regulatory Approval?

What Roles Do Pharmacists Play in Pharma?

What is a New Drug Application (NDA)?

Partnered Content Networks

Relevant Topics